Revolutionary At-Home Test Combines COVID-19 and Flu Detection, Now Available in the U.S. During Sale Process

Lucira Health, Inc., a medical technology company, is excited to announce the launch of its revolutionary Lucira COVID-19 & Flu Home Test in the United States, as well as its inclusion in the Australian Register of Therapeutic Goods (ARTG) for use by healthcare professionals.

The COVID-19 & Flu Home Test is the first and only combination COVID-19 & Flu test to receive an emergency use authorization (EUA) from the FDA for over the counter (OTC) use at home and other non-laboratory sites. With similar performance to highly sensitive lab-based PCR tests, this easy-to-use, all-in-one test delivers results in 30 minutes or less from one shallow nasal swab. Get yours today for the introductory price of $34.99!

Lucira Health’s President and CEO, Erik Engelson, is proud to announce two major milestones for the company: receiving clearance from the U.S.

Food and Drug Administration (FDA) for its at-home diagnostic tests for SARS-CoV-2, the virus that causes COVID-19, and influenza A and B viruses, and launching the Lucira Connect web platform, offering one-touch access to telehealth after receiving a test result. With this, U.S. consumers can now get a diagnosis and begin the path to treatment and recovery from the comfort of home within hours.

We are thrilled to announce that our COVID-19 & Flu Test has been included in the Australian Register of Therapeutic Goods! As the flu season in the United States winds down, it is likely to pick up in the southern hemisphere, and our combination test provides an opportunity for patients to quickly access diagnosis and treatment in Australia.

These authorizations demonstrate the future potential of our products, and we are actively seeking a strategic or financial partner to resume manufacturing and develop additional home diagnostic products.

About the Lucira COVID-19 & Flu Home Test

Lucira’s COVID-19 & Flu Home Test is a revolutionary molecular, nucleic acid amplification (NAAT) test, giving you the power of a lab-quality single-use test in the palm of your hand! Results for COVID-19, Flu A and Flu B can be achieved in 30 minutes or less with just one shallow nasal swab – no extra reader or instrument required. With no extra equipment to buy or maintain, the Lucira test is the perfect solution for safe, fast, and reliable home testing.

About Lucira Health

Lucira is revolutionizing the world of medical diagnostics. By making lab-quality results accessible anywhere and at any time, they are providing accurate, reliable tests for a wide range of infectious diseases, including COVID-19 and Flu. But they don’t stop there! Lucira is also developing tests for respiratory infections, women’s health, and STIs, making their impact even more far-reaching. With Lucira, the future of diagnostics is here.

Leave a Comment